Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviz Technologies (INVZ) Common Equity (2019 - 2025)

Historic Common Equity for Innoviz Technologies (INVZ) over the last 7 years, with Q3 2025 value amounting to $89.7 million.

  • Innoviz Technologies' Common Equity fell 319.67% to $89.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.7 million, marking a year-over-year decrease of 319.67%. This contributed to the annual value of $78.9 million for FY2024, which is 4850.97% down from last year.
  • Innoviz Technologies' Common Equity amounted to $89.7 million in Q3 2025, which was down 319.67% from $93.1 million recorded in Q2 2025.
  • Innoviz Technologies' Common Equity's 5-year high stood at $298.8 million during Q4 2021, with a 5-year trough of $78.9 million in Q4 2024.
  • Moreover, its 5-year median value for Common Equity was $112.7 million (2024), whereas its average is $139.4 million.
  • Per our database at Business Quant, Innoviz Technologies' Common Equity soared by 23354.58% in 2021 and then crashed by 4850.97% in 2024.
  • Over the past 5 years, Innoviz Technologies' Common Equity (Quarter) stood at $298.8 million in 2021, then plummeted by 35.74% to $192.0 million in 2022, then fell by 20.17% to $153.3 million in 2023, then plummeted by 48.51% to $78.9 million in 2024, then increased by 13.6% to $89.7 million in 2025.
  • Its Common Equity stands at $89.7 million for Q3 2025, versus $93.1 million for Q2 2025 and $107.8 million for Q1 2025.